Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 211

1.

Role of intracardiac echocardiography for guiding ablation of tricuspid valve arrhythmias.

Enriquez A, Tapias C, Rodriguez D, Ramirez J, Rosso R, Viskin S, Schaller R, Marchlinski F, Saenz L, Garcia F.

HeartRhythm Case Rep. 2018 May 7;4(6):209-213. doi: 10.1016/j.hrcr.2018.02.010. eCollection 2018 Jun. No abstract available.

2.

Read My Lips: A Positive Ajmaline Test Does Not Always Mean You Have Brugada Syndrome.

Viskin S, Rosso R.

JACC Clin Electrophysiol. 2017 Dec 11;3(12):1409-1411. doi: 10.1016/j.jacep.2017.05.016. Epub 2017 Aug 30. No abstract available.

PMID:
29759672
3.

Type-I Paradox of Brugada Syndrome.

Viskin S, Hochstadt A, Rosso R.

J Am Heart Assoc. 2018 May 10;7(10). pii: e009298. doi: 10.1161/JAHA.118.009298. No abstract available.

4.

Radiofrequency Ablation of Asymptomatic Brugada Syndrome: Don't Go Burning My Heart.

Viskin S.

Circulation. 2018 May 1;137(18):1883-1884. doi: 10.1161/CIRCULATIONAHA.117.032624. Epub 2018 Mar 12. No abstract available.

PMID:
29530885
5.

New formula for defining "normal" and "prolonged" QT in patients with bundle branch block.

Yankelson L, Hochstadt A, Sadeh B, Pick B, Finkelstein A, Rosso R, Viskin S.

J Electrocardiol. 2018 May - Jun;51(3):481-486. doi: 10.1016/j.jelectrocard.2017.12.039. Epub 2018 Jan 31.

PMID:
29395105
6.

Should theophylline be added to the J wave syndrome therapeutic armamentarium?

Antzelevitch C, Viskin S.

Pacing Clin Electrophysiol. 2018 May;41(5):439-440. doi: 10.1111/pace.13237. Epub 2017 Dec 13. No abstract available.

PMID:
29148067
7.

Theophylline: The forgotten antiarrhythmic drug… now for malignant early repolarization.

Viskin S, Havakuk O, Antzelevitch C, Rosso R.

Pacing Clin Electrophysiol. 2018 May;41(5):441-443. doi: 10.1111/pace.13239. Epub 2017 Dec 7. No abstract available.

PMID:
29148055
8.

Attempts to prevent "tongue swallowing" may well be the main obstacle for successful bystander resuscitation of athletes with cardiac arrest.

Viskin D, Rosso R, Havakuk O, Yankelson L, Viskin S.

Heart Rhythm. 2017 Nov;14(11):1729-1734. doi: 10.1016/j.hrthm.2017.08.012. Epub 2017 Sep 19. No abstract available.

PMID:
28939206
9.

Idiopathic Polymorphic Ventricular Tachycardia: a "Benign Disease" with a Touch of Bad Luck?

Viskin S.

Korean Circ J. 2017 May;47(3):299-306. doi: 10.4070/kcj.2016.0303. Epub 2017 May 25. Review.

10.

J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

Antzelevitch C, Yan GX, Ackerman MJ, Borggrefe M, Corrado D, Guo J, Gussak I, Hasdemir C, Horie M, Huikuri H, Ma C, Morita H, Nam GB, Sacher F, Shimizu W, Viskin S, Wilde AAM.

Europace. 2017 Apr 1;19(4):665-694. doi: 10.1093/europace/euw235. Review. No abstract available.

11.

Long-term flecainide therapy in type 3 long QT syndrome.

Chorin E, Taub R, Medina A, Flint N, Viskin S, Benhorin J.

Europace. 2018 Feb 1;20(2):370-376. doi: 10.1093/europace/euw439.

PMID:
28339995
12.

Reply to the Editor-Minimal QT, not just maximal, may underlie Tdp risk in women.

Chorin E, Viskin S, Rosso R.

Heart Rhythm. 2017 May;14(5):e51. doi: 10.1016/j.hrthm.2017.01.039. Epub 2017 Jan 31. No abstract available.

PMID:
28153796
13.

Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE.

Mont L, Pelliccia A, Sharma S, Biffi A, Borjesson M, Brugada Terradellas J, Carré F, Guasch E, Heidbuchel H, La Gerche A, Lampert R, McKenna W, Papadakis M, Priori SG, Scanavacca M, Thompson P, Sticherling C, Viskin S, Wilson M, Corrado D; Reviewers, Lip GY, Gorenek B, Blomström Lundqvist C, Merkely B, Hindricks G, Hernández-Madrid A, Lane D, Boriani G, Narasimhan C, Marquez MF, Haines D, Mackall J, Manuel Marques-Vidal P, Corra U, Halle M, Tiberi M, Niebauer J, Piepoli M.

Eur J Prev Cardiol. 2017 Jan;24(1):41-69. Epub 2016 Nov 4. Review. No abstract available.

PMID:
27815537
14.

Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE.

Mont L, Pelliccia A, Sharma S, Biffi A, Borjesson M, Terradellas JB, Carré F, Guasch E, Heidbuchel H, Gerche A, Lampert R, McKenna W, Papadakis M, Priori SG, Scanavacca M, Thompson P, Sticherling C, Viskin S, Wilson M, Corrado D, Lip GY, Gorenek B, Lundqvist CB, Merkely B, Hindricks G, Hernández-Madrid A, Lane D, Boriani G, Narasimhan C, Marquez MF, Haines D, Mackall J, Marques-Vidal PM, Corra U, Halle M, Tiberi M, Niebauer J, Piepoli M.

Europace. 2017 Jan;19(1):139-163. doi: 10.1093/europace/euw243. Epub 2016 Nov 4. No abstract available.

PMID:
27815371
15.

Erratum to '2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing' [Journal of Arrhythmia 32/1 (2016) 1-28].

Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, Aguinaga L, Berger RD, Cuesta A, Daubert JP, Dubner S, Ellenbogen KA, Mark Estes NA 3rd, Fenelon G, Garcia FC, Gasparini M, Haines DE, Healey JS, Hurtwitz JL, Keegan R, Kolb C, Kuck KH, Marinskis G, Martinelli M, McGuire M, Molina LG, Okumura K, Proclemer A, Russo AM, Singh JP, Swerdlow CD, Teo WS, Uribe W, Viskin S, Wang CC, Zhang S.

J Arrhythm. 2016 Oct;32(5):441-442. Epub 2016 Sep 21.

16.

J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

Antzelevitch C, Yan GX, Ackerman MJ, Borggrefe M, Corrado D, Guo J, Gussak I, Hasdemir C, Horie M, Huikuri H, Ma C, Morita H, Nam GB, Sacher F, Shimizu W, Viskin S, Wilde AA.

J Arrhythm. 2016 Oct;32(5):315-339. Epub 2016 Aug 21. No abstract available.

17.

Ranolazine for Congenital Long-QT Syndrome Type III: Experimental and Long-Term Clinical Data.

Chorin E, Hu D, Antzelevitch C, Hochstadt A, Belardinelli L, Zeltser D, Barajas-Martinez H, Rozovski U, Rosso R, Adler A, Benhorin J, Viskin S.

Circ Arrhythm Electrophysiol. 2016 Oct;9(10). pii: e004370.

18.

Female gender as independent risk factor of torsades de pointes during acquired atrioventricular block.

Chorin E, Hochstadt A, Viskin S, Rozovski U, Havakuk O, Baranchuk A, Enriquez A, Strasberg B, Guevara-Valdivia ME, Márquez MF, González-Pacheco H, Hasdemir C, Rosso R.

Heart Rhythm. 2017 Jan;14(1):90-95. doi: 10.1016/j.hrthm.2016.09.013. Epub 2016 Sep 17.

PMID:
27650425
19.

Exercise-induced Ventricular Tachycardia/Ventricular Fibrillation in the Normal Heart: Risk Stratification and Management.

Michowitz Y, Viskin S, Rosso R.

Card Electrophysiol Clin. 2016 Sep;8(3):593-600. doi: 10.1016/j.ccep.2016.04.008. Epub 2016 Jun 18. Review.

PMID:
27521092
20.

Radiofrequency Ablation of Atrial Fibrillation: Nonrandomized Comparison of Circular versus Point-by-Point "Smart" Ablation for Achieving Circumferential Pulmonary Vein Isolation and Curing Arrhythmic Symptoms.

Rosso R, Chorin E, Levi Y, Rogowski O, Viskin S.

J Cardiovasc Electrophysiol. 2016 Jul 29. doi: 10.1111/jce.13058. [Epub ahead of print]

PMID:
27468731
21.

J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

Antzelevitch C, Yan GX, Ackerman MJ, Borggrefe M, Corrado D, Guo J, Gussak I, Hasdemir C, Horie M, Huikuri H, Ma C, Morita H, Nam GB, Sacher F, Shimizu W, Viskin S, Wilde AA.

Heart Rhythm. 2016 Oct;13(10):e295-324. doi: 10.1016/j.hrthm.2016.05.024. Epub 2016 Jul 13. Review. No abstract available.

22.

Reply: Long-QT Syndrome, Brugada Syndrome, and Catecholaminergic Polymorphic Ventricular Tachycardia: A Tale of 3 Diseases : Ibutilide as a Torsade de Pointes Stress Test.

Havakuk O, Viskin S.

J Am Coll Cardiol. 2016 Jun 14;67(23):2806-2807. doi: 10.1016/j.jacc.2016.03.553. No abstract available.

23.

Clinical Features of Genetic Cardiac Diseases Related to Potassium Channelopathies.

Adler A, Viskin S.

Card Electrophysiol Clin. 2016 Jun;8(2):361-72. doi: 10.1016/j.ccep.2016.02.001. Review.

PMID:
27261827
24.

Drug-induced Brugada syndrome: Clinical characteristics and risk factors.

Konigstein M, Rosso R, Topaz G, Postema PG, Friedensohn L, Heller K, Zeltser D, Belhassen B, Adler A, Viskin S.

Heart Rhythm. 2016 May;13(5):1083-7. doi: 10.1016/j.hrthm.2016.03.016.

PMID:
27131070
25.

Electrocardiographic Early Repolarization: A Scientific Statement From the American Heart Association.

Patton KK, Ellinor PT, Ezekowitz M, Kowey P, Lubitz SA, Perez M, Piccini J, Turakhia M, Wang P, Viskin S; American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology and Council on Functional Genomics and Translational Biology.

Circulation. 2016 Apr 12;133(15):1520-9. doi: 10.1161/CIR.0000000000000388. Epub 2016 Mar 7. No abstract available.

26.

Prognostic significance of fever-induced Brugada syndrome.

Mizusawa Y, Morita H, Adler A, Havakuk O, Thollet A, Maury P, Wang DW, Hong K, Gandjbakhch E, Sacher F, Hu D, Amin AS, Lahrouchi N, Tan HL, Antzelevitch C, Probst V, Viskin S, Wilde AA.

Heart Rhythm. 2016 Jul;13(7):1515-20. doi: 10.1016/j.hrthm.2016.03.044. Epub 2016 Mar 23.

PMID:
27033637
27.

2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.

Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, Aguinaga L, Berger RD, Cuesta A, Daubert JP, Dubner S, Ellenbogen KA, Estes NA 3rd, Fenelon G, Garcia FC, Gasparini M, Haines DE, Healey JS, Hurtwitz JL, Keegan R, Kolb C, Kuck KH, Marinskis G, Martinelli M, McGuire M, Molina LG, Okumura K, Proclemer A, Russo AM, Singh JP, Swerdlow CD, Teo WS, Uribe W, Viskin S, Wang CC, Zhang S.

J Arrhythm. 2016 Feb;32(1):1-28. doi: 10.1016/j.joa.2015.12.001. Epub 2016 Feb 1. No abstract available. Erratum in: J Arrhythm. 2016 Oct;32(5):441-442.

28.

A Tale of 2 Diseases: The History of Long-QT Syndrome and Brugada Syndrome.

Havakuk O, Viskin S.

J Am Coll Cardiol. 2016 Jan 5;67(1):100-8. doi: 10.1016/j.jacc.2015.10.020. Review.

29.

Malignant early repolarization: It's the T-wave, stupid….

Viskin S, Havakuk O, Antzelevitch C, Rosso R.

Heart Rhythm. 2016 Apr;13(4):903-4. doi: 10.1016/j.hrthm.2015.12.017. Epub 2015 Dec 9. No abstract available.

PMID:
26690063
30.

2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.

Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, Aguinaga L, Berger RD, Cuesta A, Daubert JP, Dubner S, Ellenbogen KA, Mark Estes NA 3rd, Fenelon G, Garcia FC, Gasparini M, Haines DE, Healey JS, Hurtwitz JL, Keegan R, Kolb C, Kuck KH, Marinskis G, Martinelli M, McGuire M, Molina LG, Okumura K, Proclemer A, Russo AM, Singh JP, Swerdlow CD, Teo WS, Uribe W, Viskin S, Wang CC, Zhang S.

Heart Rhythm. 2016 Feb;13(2):e50-86. doi: 10.1016/j.hrthm.2015.11.018. Epub 2015 Dec 1. No abstract available.

PMID:
26607062
31.

2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.

Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, Aguinaga L, Berger RD, Cuesta A, Daubert JP, Dubner S, Ellenbogen KA, Estes NA 3rd, Fenelon G, Garcia FC, Gasparini M, Haines DE, Healey JS, Hurtwitz JL, Keegan R, Kolb C, Kuck KH, Marinskis G, Martinelli M, Mcguire M, Molina LG, Okumura K, Proclemer A, Russo AM, Singh JP, Swerdlow CD, Teo WS, Uribe W, Viskin S, Wang CC, Zhang S; Document Reviewers.

Europace. 2016 Feb;18(2):159-83. doi: 10.1093/europace/euv411. Epub 2015 Nov 19. No abstract available. Erratum in: Europace. 2017 Apr 1;19(4):580.

PMID:
26585598
32.

Pro-Arrhythmic Effects of Noncardiac Medications: Lessons From Macrolide Antibiotics.

Viskin S, Havakuk O, Schwaber MJ.

J Am Coll Cardiol. 2015 Nov 17;66(20):2185-2188. doi: 10.1016/j.jacc.2015.09.027. No abstract available.

33.

Electrocardiographic Manifestations of Calcium Abnormalities.

Chorin E, Rosso R, Viskin S.

Ann Noninvasive Electrocardiol. 2016 Jan;21(1):7-9. doi: 10.1111/anec.12316. Epub 2015 Nov 2. No abstract available.

PMID:
26524386
34.

Determinants of Effort Intolerance in Patients With Heart Failure: Combined Echocardiography and Cardiopulmonary Stress Protocol.

Shimiaie J, Sherez J, Aviram G, Megidish R, Viskin S, Halkin A, Ingbir M, Nesher N, Biner S, Keren G, Topilsky Y.

JACC Heart Fail. 2015 Oct;3(10):803-14. doi: 10.1016/j.jchf.2015.05.010.

35.

Management of Brugada Syndrome: Thirty-Three-Year Experience Using Electrophysiologically Guided Therapy With Class 1A Antiarrhythmic Drugs.

Belhassen B, Rahkovich M, Michowitz Y, Glick A, Viskin S.

Circ Arrhythm Electrophysiol. 2015 Dec;8(6):1393-402. doi: 10.1161/CIRCEP.115.003109. Epub 2015 Sep 9.

36.

Risk stratification in Brugada syndrome: Clinical characteristics, electrocardiographic parameters, and auxiliary testing.

Adler A, Rosso R, Chorin E, Havakuk O, Antzelevitch C, Viskin S.

Heart Rhythm. 2016 Jan;13(1):299-310. doi: 10.1016/j.hrthm.2015.08.038. Epub 2015 Sep 1. Review.

PMID:
26341603
37.

Call "the Cleaners": How to Treat Drug-Induced Torsades de Pointes.

Viskin S, Antzelevitch C, Rosso R.

JACC Clin Electrophysiol. 2015 Aug;1(4):323-325. doi: 10.1016/j.jacep.2015.07.002. Epub 2015 Jul 11. No abstract available.

38.

Diagnostic value of T-wave morphology changes during "QT stretching" in patients with long QT syndrome.

Chorin E, Havakuk O, Adler A, Steinvil A, Rozovski U, van der Werf C, Postema PG, Topaz G, Wilde AA, Viskin S, Rosso R.

Heart Rhythm. 2015 Nov;12(11):2263-71. doi: 10.1016/j.hrthm.2015.06.040. Epub 2015 Jun 30.

PMID:
26142298
39.

Syncope in Hereditary Arrhythmogenic Syndromes.

Adler A, Viskin S.

Cardiol Clin. 2015 Aug;33(3):433-40. doi: 10.1016/j.ccl.2015.04.011. Review.

PMID:
26115829
40.

From whole exome sequencing to patient-specific therapy: another example of how basic research pays off in patient care.

Wilde AA, Viskin S.

J Am Heart Assoc. 2015 May 26;4(5). pii: 002085. doi: 10.1161/JAHA.115.002085. No abstract available.

41.

Everybody has Brugada syndrome until proven otherwise?

Viskin S, Rosso R, Friedensohn L, Havakuk O, Wilde AA.

Heart Rhythm. 2015 Jul;12(7):1595-8. doi: 10.1016/j.hrthm.2015.04.017. Epub 2015 May 18. No abstract available.

PMID:
25998201
42.

Reply: life-threatening events during endurance sports: is heat stroke more prevalent than arrhythmic death?

Yankelson L, Steinvil A, Adler A, Viskin S.

J Am Coll Cardiol. 2015 Feb 3;65(4):408-409. doi: 10.1016/j.jacc.2014.10.054. No abstract available.

43.

Early repolarization and arrhythmic death: six more years?

Rosso R, Viskin S.

Trends Cardiovasc Med. 2015 Jan;25(1):31-2. doi: 10.1016/j.tcm.2014.09.008. Epub 2014 Sep 28. No abstract available.

PMID:
25446048
44.

Atrial fibrillation, stroke, and mortality rates after transcatheter aortic valve implantation.

Yankelson L, Steinvil A, Gershovitz L, Leshem-Rubinow E, Furer A, Viskin S, Keren G, Banai S, Finkelstein A.

Am J Cardiol. 2014 Dec 15;114(12):1861-6. doi: 10.1016/j.amjcard.2014.09.025. Epub 2014 Sep 28.

PMID:
25438914
45.

Long QT syndrome complicating atrioventricular block: arrhythmogenic effects of cardiac memory.

Rosso R, Adler A, Strasberg B, Guevara-Valdivia ME, Somani R, Baranchuk A, Halkin A, Márquez MF, Scheinman M, Steinvil A, Belhassen B, Kazatsker M, Katz A, Viskin S.

Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1129-35. doi: 10.1161/CIRCEP.114.002085. Epub 2014 Oct 13.

46.

Near fatal ventricular fibrillation in Brugada syndrome despite presence of an implanted implantable cardioverter defibrillator.

Belhassen B, Viskin S.

Can J Cardiol. 2014 Nov;30(11):1460.e3-5. doi: 10.1016/j.cjca.2014.06.015. Epub 2014 Jun 27.

PMID:
25240706
47.

Assessment of the 12-lead electrocardiogram as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 years of age): a scientific statement from the American Heart Association and the American College of Cardiology.

Maron BJ, Friedman RA, Kligfield P, Levine BD, Viskin S, Chaitman BR, Okin PM, Saul JP, Salberg L, Van Hare GF, Soliman EZ, Chen J, Matherne GP, Bolling SF, Mitten MJ, Caplan A, Balady GJ, Thompson PD; American Heart Association Council on Clinical Cardiology; Advocacy Coordinating Committee; Council on Cardiovascular Disease in the Young; Council on Cardiovascular Surgery and Anesthesia; Council on Epidemiology and Prevention; Council on Functional Genomics and Translational Biology; Council on Quality of Care and Outcomes Research, and American College of Cardiology.

J Am Coll Cardiol. 2014 Oct 7;64(14):1479-514. doi: 10.1016/j.jacc.2014.05.006. Epub 2014 Sep 15. No abstract available.

48.

Assessment of the 12-lead ECG as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 Years of Age): a scientific statement from the American Heart Association and the American College of Cardiology.

Maron BJ, Friedman RA, Kligfield P, Levine BD, Viskin S, Chaitman BR, Okin PM, Saul JP, Salberg L, Van Hare GF, Soliman EZ, Chen J, Matherne GP, Bolling SF, Mitten MJ, Caplan A, Balady GJ, Thompson PD; American Heart Association Council on Clinical Cardiology, Advocacy Coordinating Committee, Council on Cardiovascular Disease in the Young, Council on Cardiovascular Surgery and Anesthesia, Council on Epidemiology and Prevention, Council on Functional Genomics and Translational Biology, Council on Quality of Care and Outcomes Research, and American College of Cardiology.

Circulation. 2014 Oct 7;130(15):1303-34. doi: 10.1161/CIR.0000000000000025. Epub 2014 Sep 15. No abstract available.

49.

Life-threatening events during endurance sports: is heat stroke more prevalent than arrhythmic death?

Yankelson L, Sadeh B, Gershovitz L, Werthein J, Heller K, Halpern P, Halkin A, Adler A, Steinvil A, Viskin S.

J Am Coll Cardiol. 2014 Aug 5;64(5):463-9. doi: 10.1016/j.jacc.2014.05.025.

50.

Arrhythmogenic right ventricular cardiomyopathy: an unusual possible cause of arrhythmia in a 78 year old man with a 40 year history of palpitations.

Belhassen B, Viskin S, Aviram G.

Isr Med Assoc J. 2014 Jun;16(6):385-7. No abstract available.

PMID:
25059004

Supplemental Content

Loading ...
Support Center